triggered brand semaglutide GLP-1s appear to cut cancer risk. Researchers are asking why and how : NPR Semaglutide and Restless Leg Syndrome:

Median deep fat compartment volume decreased by 7%, but with a much wider IQR of 20% to 15%, meaning some patients actually gained deep compartment volume while others lost substantially more

For higher doses requiring 40+ units, the standard 1 mL syringe is more practical

Publication Details Paper Title: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation | Authors: Huilin Tang, Bingyu Zhang, Yiwen Lu, Dazheng Zhang, Ruishan Liu, Yuan Lu, George Cotsarelis, David A

Due to their ability to communicate intercellularly, they have low immunogenicity, minimal toxicity, biodegradable nature, and the ability to cross biological barriers, MSC-Exos have become promising vehicles for various biomolecules and chemical agents in cancer treatment